Last reviewed · How we verify
NCT07004192
The Role of hCG in Thawed Embryo Transfer
Phase 4 trial testing HCG injection in Infertility (IVF Patients) in 220 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | Fertility Center of Las Vegas |
|---|---|
| Phase | Phase 4 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 220 |
| Start date | 2 June 2025 |
| Primary completion | 31 December 2027 |
| Estimated completion | 31 December 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- HCG injection — full drug profile →
- No intervention
Conditions studied
- Infertility (IVF Patients) — all drugs for Infertility (IVF Patients) →
Sponsor
Fertility Center of Las Vegas — full company profile →
Who can join
18 and older, female only, with Infertility (IVF Patients). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07004192
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of HCG injection
Trials testing the same drug.
- NCT07523022 — Comparison of the Effect of Gonadotropin and Clomiphene Citrate Treatment on Sperm Parameters and the Outcome of Assiste · Phase 4 · enrolling by invitation
Other recruiting trials for Infertility (IVF Patients)
Currently open trials in the same condition.
- NCT07185724 — Ketorolac Use and Fresh Embryo Transfer Outcomes · Phase 4 · recruiting
- NCT07323329 — Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization · Phase 2, PHASE3 · recruiting
- NCT07148999 — An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera · Phase 1, PHASE2 · recruiting
- NCT06717802 — Endometrial Receptivity Prediction During in Vitro Fertilization Using Artificial Intelligence · recruiting
- NCT06799507 — The Effect of Mindfulness-Based Lifestyle Support Program on Infertile Women · NA · recruiting
Other Fertility Center of Las Vegas trials
Trials by the same sponsor.
- NCT06133803 — Lovenox With Aspirin in Thawed Blastocyst Transfer · Phase 4 · unknown
- NCT05498350 — Randomized Trial Comparing Early "Trigger" Versus Delayed "Trigger" Timing in Cycles of Controlled Ovarian Stimulation. · NA · unknown
- NCT04096027 — Cabergoline Before or After Oocyte Collection for Follicular Resolution · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07004192 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fertility Center of Las Vegas
- Last refreshed: 1 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07004192.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing